Abstract
Sub-Saharan Africa is facing a rising epidemic of coronary artery disease (CAD). The chromosome locus 9p21.3, containing the long non-coding RNA CDKN2B-AS1, is a known hotspot for CAD risk, yet its role in African populations remains understudied. This study evaluated common polymorphisms in this locus among 155 Tanzanian CAD patients from different regions. Results showed significant differences in genotype and allele frequencies for rs10757274, rs10757278, and rs10811656 between Northern (N-CAD) and other (R-CAD) regions. A novel three-marker risk haplotype (G-G-G) was identified as overrepresented in the N-CAD group. Combining genetic risk factors with non-genetic factors improved the diagnostic model's AUC from 0.730 to 0.784, suggesting these variants are significant biomarkers for CAD in Northern Tanzania.
Introduction
Coronary artery disease (CAD) is becoming a leading cause of morbidity in Sub-Saharan Africa due to rapid urbanization and lifestyle changes. While the 9p21.3 locus is a well-established risk factor in European and Asian populations, its impact in African cohorts is less clear and often inconsistent across regions. This study investigates the association of variants within the CDKN2B-AS1 (also known as ANRIL) gene with CAD risk in the diverse tribal populations of Tanzania, specifically focusing on the Northern region where the Chagga tribe predominates.
Methods
A cross-sectional study was conducted with 155 Tanzanian CAD patients recruited from the Jakaya Kikwete Cardiac Institute. Participants were categorized into two groups: 90 from the Northern region (N-CAD) and 65 from other regions (R-CAD: South, East, West, and Central). Biochemical profiles, including BMI, fasting glucose, and lipid levels, were recorded. Genotyping of six specific Single Nucleotide Polymorphisms (SNPs) at the 9p21.3 locus was performed using Quantitative Real-Time PCR (qRT-PCR) with the LightSNiP typing assay. Haplotype analysis was conducted using Haploview 4.2, and the predictive value of genetic markers was assessed using Area Under the Curve (AUC) Receiver Operating Characteristic (ROC) models.
Results
The study revealed that patients from Northern Tanzania exhibited significantly higher clinical risk factors and a distinct genetic profile compared to those from other regions. Three specific SNPs—rs10757274, rs10757278, and rs10811656—showed strong statistical associations with CAD risk (p < 0.05).
The G allele of rs10757274 was particularly notable, associated with a 3.07-fold increase in CAD risk in the Northern group (95% CI: 1.89–4.97). Furthermore, a novel three-marker risk haplotype (G-G-G, comprising rs1333049, rs10757274, and rs10757278) was identified as significantly overrepresented in the N-CAD group. Integrating these genetic markers into a clinical risk model significantly enhanced diagnostic accuracy.
As shown in Table 2, the baseline model using only non-genetic factors (BMI, cholesterol, triglycerides, glucose) yielded an AUC of 0.730. The addition of the three key SNPs improved the AUC to 0.784 (p < 0.0001), indicating a robust improvement in diagnostic performance.
Discussion and Conclusion
The findings highlight significant intra-country genetic and phenotypic diversity within Tanzania. Interestingly, the SNP frequencies in this Tanzanian cohort were more similar to European populations than to other African regions, suggesting complex ancestral links. Mechanistically, these intronic variants in CDKN2B-AS1 likely disrupt transcription factor binding sites (e.g., for STAT1), modulating inflammatory signaling pathways critical to atherosclerosis.
The study concludes that CDKN2B-AS1 variants are potent risk markers for CAD in Northern Tanzania. Their inclusion in clinical models provides a "good" level of diagnostic accuracy, potentially serving as prognostic biomarkers. While limited by a relatively small sample size and the lack of a healthy control group, this research provides a vital foundation for personalized cardiovascular medicine in East Africa.
Summary updated